Treatment of CESD in humans consists of a low‐fat diet, cholesterol‐lowering drugs, and long‐term enzyme replacement therapy using sebelipase alfa, which is recombinant human LAL [3]. The gene discussed is LIPA; the disease is cholesteryl ester storage disease.